Latest filing published 02 Nov 2009 for CytoDyn Inc., €652k.
First 200 filings with a declared amount
No signal scores available.
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
This profile gathers the share dealings of Utek Corp across 15 companies, led by Material Technologies Inc /CA/, NextPlat Corp and American Soil Technologies Inc. Between 9 March 2006 and 30 September 2009, the trades on record add up to 216 filings.
Market trades split into 15 purchases (€16.6M) and 193 sales (€12.4M). No amount is published for 5 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 1 share grant. In 2009 alone, the filings show 7 purchases and 51 sales.
Half of the purchases are above €1.3M and half below. Looking at 4 purchases old enough to measure, the stock rose over the following 90 days in 0% of cases; the median change was -47.1%. This is a record of the past, not a forecast.
The newest entry dates from 2 November 2009: an open-market purchase of €652k, in CytoDyn Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 216 declarations